These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 626124)

  • 1. Progressive nature of myocardial injury in selected patients with cardiogenic shock.
    Gutovitz AL; Sobel BE; Roberts R
    Am J Cardiol; 1978 Mar; 41(3):469-75. PubMed ID: 626124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial infarct size and cardiogenic shock.
    Grande P; Christiansen C; Hansen BF
    Eur Heart J; 1983 May; 4(5):289-94. PubMed ID: 6617675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early appearance of MB-creatine kinase activity in nontransmural myocardial infarction detected by a sensitive assay for the isoenzyme.
    Shell WE; DeWood MA; Kligerman M; Ganz W; Swan HJ
    Am J Med; 1981 Aug; 71(2):254-62. PubMed ID: 7258219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated creatine kinase MB isoenzyme levels in marathon runners. Normal myocardial scintigrams suggest noncardiac source.
    Siegel AJ; Silverman LM; Holman BL
    JAMA; 1981 Nov; 246(18):2049-51. PubMed ID: 7288991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activity of certain blood enzymes in patients with myocardial infarct complicated by shock].
    Bart BI; Gratsianskiĭ NA
    Kardiologiia; 1975 Feb; 15(2):84-9. PubMed ID: 1123885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of serum cardiac enzymes after intracoronary thrombolytic therapy. Creatine kinase, creatine kinase MB isozyme, lactate dehydrogenase, and serum glutamic-oxaloacetic transaminase.
    Wei JY; Markis JE; Malagold M; Grossman W
    Arch Intern Med; 1985 Sep; 145(9):1596-600. PubMed ID: 4026489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group.
    Hands ME; Rutherford JD; Muller JE; Davies G; Stone PH; Parker C; Braunwald E
    J Am Coll Cardiol; 1989 Jul; 14(1):40-6; discussion 47-8. PubMed ID: 2738272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction.
    Lewis BS; Ganz W; Laramee P; Cercek B; Hod H; Shah PK; Lew AS
    Am J Cardiol; 1988 Jul; 62(1):20-4. PubMed ID: 3381752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
    Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
    Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage.
    Haider AW; Andreotti F; Hackett DR; Tousoulis D; Kluft C; Maseri A; Davies GJ
    J Am Coll Cardiol; 1995 Sep; 26(3):662-7. PubMed ID: 7642856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of acute myocardial infarct size in man by serum CK-MB measurements.
    Grande P; Hansen BF; Christiansen C; Naestoft J
    Circulation; 1982 Apr; 65(4):756-64. PubMed ID: 7060254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin T and cardiac enzymes after external transthoracic cardioversion of ventricular arrhythmias in patients with coronary artery disease.
    Goktekin O; Melek M; Gorenek B; Birdane A; Kudaiberdieva G; Cavusoglu Y; Timuralp B
    Chest; 2002 Dec; 122(6):2050-4. PubMed ID: 12475846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction.
    Cheng JM; van Leeuwen MA; de Boer SP; Wai MC; den Uil CA; Jewbali LS; van Geuns RJ; Kardys I; van Domburg RT; Boersma E; Zijlstra F; Akkerhuis KM
    Int J Cardiol; 2013 Oct; 168(4):3758-63. PubMed ID: 23830073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The loss of electrically active myocardium in cardiogenic shock.
    Selwyn AP; Ogunro E; Shillingford JP
    Eur J Cardiol; 1978 Jan; 6(5):337-46. PubMed ID: 624315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strategy for the use of cardiac injury markers (troponin I and T, creatine kinase-MB mass and isoforms, and myoglobin) in the diagnosis of acute myocardial infarction.
    Kost GJ; Kirk JD; Omand K
    Arch Pathol Lab Med; 1998 Mar; 122(3):245-51. PubMed ID: 9823862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients.
    Ravkilde J; Nissen H; Hørder M; Thygesen K
    J Am Coll Cardiol; 1995 Mar; 25(3):574-81. PubMed ID: 7860899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peri-operative myocardial injury in patients undergoing surgery for critical limb ischaemia.
    Hobbs SD; Yapanis M; Burns PJ; Wilmink AB; Bradbury AW; Adam DJ
    Eur J Vasc Endovasc Surg; 2005 Mar; 29(3):301-4. PubMed ID: 15694805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality at 30 days in high-risk patients treated with direct or rescue stenting for acute myocardial infarction: a single center experience.
    La Vecchia L; Martini M; Sartori M; Vincenzi P; Cischele L; Righetti T; Ometto R; Fontanelli A
    J Invasive Cardiol; 2001 Oct; 13(10):689-93. PubMed ID: 11581511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of disappearance of creatine kinase-MB after acute myocardial infarction: clinical determinants of variability.
    Lee RT; Lee TH; Poole WK; Gustafson N; Stone PH; Jaffe AS; Muller JE; Sobel BE; Roberts R; Braunwald E
    Am Heart J; 1988 Dec; 116(6 Pt 1):1493-9. PubMed ID: 3195433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.